XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Unaudited Condensed Consolidated Statements of Shareholders Equity - USD ($)
Common stock
Treasury stock
Additional paid-in capital
Retained earnings/(Accumulated deficit)
Total
Balance at Mar. 31, 2022 $ 513,217 $ (121,226,936) $ 760,105,994 $ 280,759,140 $ 920,151,415
Balance (in shares) at Mar. 31, 2022 51,321,695        
Increase (Decrease) in Shareholders' Equity          
Net income for the period       24,847,720 24,847,720
Restricted share award issuances $ 158   (158)    
Restricted share award issuances (in shares) 15,750        
Dividend       (100,337,605) (100,337,605)
Stock-based compensation     658,872   658,872
Purchase of treasury stock   (971,067)     (971,067)
Balance at Jun. 30, 2022 $ 513,375 (122,198,003) 760,764,708 205,269,255 844,349,335
Balance (in shares) at Jun. 30, 2022 51,337,445        
Balance at Mar. 31, 2023 $ 516,306 (122,896,838) 764,383,292 231,843,562 873,846,322
Balance (in shares) at Mar. 31, 2023 51,630,593        
Increase (Decrease) in Shareholders' Equity          
Net income for the period       51,721,137 51,721,137
Restricted share award issuances $ 238   (238)    
Restricted share award issuances (in shares) 23,750        
Dividend       (40,382,730) (40,382,730)
Stock-based compensation     776,607   776,607
Purchase of treasury stock   (352,627)     (352,627)
Balance at Jun. 30, 2023 $ 516,544 $ (123,249,465) $ 765,159,661 $ 243,181,969 $ 885,608,709
Balance (in shares) at Jun. 30, 2023 51,654,343